Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Evolving challenges in hepatic fibrosis
Scott L. Friedman
CTSA ConduITS - Institutes for Translational Sciences
Cancer Mechanisms
Friedman Brain Institute
Graduate School of Biomedical Sciences
Icahn School of Medicine at Mount Sinai
Liver Cancer
Medicine
Medicine - Liver Diseases
Pharmacological Sciences
Mount Sinai Tisch Cancer Center
Hepatology Transplant Fellowship Program
Research output
:
Contribution to journal
›
Review article
›
peer-review
556
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Evolving challenges in hepatic fibrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Fibrogenesis
100%
Chemokine
50%
Cell Activation
50%
Gene Control
50%
Oxidoreductase
50%
Hepatic Stellate Cell
50%
Innate Immunity
50%
Rigidity
50%
Awareness
50%
Oxidase
50%
Myofibroblast
50%
Adipokine
50%
Programmed Cell Death
50%
Keyphrases
Hepatic Fibrosis
100%
Apoptosis
25%
Chemokines
25%
Extracellular Matrix
25%
New Therapies
25%
Chronic Liver Disease
25%
Gene Regulation
25%
Liver Fibrosis
25%
Hepatic Stellate Cell Activation
25%
Fibrogenic
25%
Enhanced Awareness
25%
Diagnostic Interventions
25%
Innate Immunity
25%
Fibrosis Regression
25%
Angiogenic
25%
Senescence
25%
Fibrogenesis
25%
Adipokines
25%
Fibrosis Progression
25%
Myofibroblast
25%
New Diagnostic Tools
25%
Translational Challenges
25%
NAPDH Oxidase
25%
Extracellular Matrix Stiffness
25%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Fibrosis
100%
Fibrosis
20%
Chemokine
20%
Chronic Liver Disease
20%
Oxidoreductase
20%
Adipocytokine
20%